Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg M Allen

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Life Science Alliance|June 13, 2023
An immune-based tool platform for in vivo cell clearanceJieqiong Zhang, Tatsuya Tsukui, Xiumin Wu, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Synthetic Hybrid Receptors for Safer and Programmable T Cell TherapyMaxwell G Foisey, Julie Garcia, Xun Li, et al.
Science (New York, N.Y.)|December 15, 2022
Synthetic cytokine circuits that drive T cells into immune-excluded tumorsGreg M Allen, Nicholas W Frankel, Nishith R Reddy, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumorsQi Liu, Peixin Amy Chen, Esha Urs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter StudyCollin M Blakely, Anatoly Urisman, Matthew A Gubens, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Ultra-large targeted DNA integrations in primary human cellsCourtney Kernick, Lauren Chow, Mikail Alejandro, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Life Science Alliance|June 13, 2023
An immune-based tool platform for in vivo cell clearanceJieqiong Zhang, Tatsuya Tsukui, Xiumin Wu, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Synthetic Hybrid Receptors for Safer and Programmable T Cell TherapyMaxwell G Foisey, Julie Garcia, Xun Li, et al.
Science (New York, N.Y.)|December 15, 2022
Synthetic cytokine circuits that drive T cells into immune-excluded tumorsGreg M Allen, Nicholas W Frankel, Nishith R Reddy, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumorsQi Liu, Peixin Amy Chen, Esha Urs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter StudyCollin M Blakely, Anatoly Urisman, Matthew A Gubens, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Ultra-large targeted DNA integrations in primary human cellsCourtney Kernick, Lauren Chow, Mikail Alejandro, et al.
Pageof 2